[Inhibitors and "bypass" therapy in hemophilia].
D000293:Adolescent; D000328:Adult; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D000941:Antigens / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D005164:Factor IX / Q000627:therapeutic use; D015949:Factor IXa; D005169:Factor VIII / Q000032:analysis / Q000037:antagonists & inhibitors* / Q000276:immunology; D006467:Hemophilia A / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D014841:von Willebrand Factor
D000933:Antifibrinolytic Agents; D000941:Antigens; D014841:von Willebrand Factor; D005169:Factor VIII; D005164:Factor IX; D015949:Factor IXa